LONA
LeonaBio, Inc.
There isn't enough reported data to score LONA yet.
LONA Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Unavailable |
LONA's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.
LONA PE Valuation
LONA has no meaningful PE right now: it lost money over the past year.
LONA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| -- | |
| -- | |
| Limited | |
| High |
Analysts expect LONA's losses to shrink, with revenue holding steady.
LONA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$23.13 | -$7.73 |
| Q1 2026 | -$24.13 | -$3.53 |
| Q4 2025 | -$24.70 | +$0.50 |
| Q3 2025 | -$9.58 | +$18.92 |
| Q2 2025 | -$15.40 | +$14.30 |
| Q1 2025 | -$20.60 | +$9.90 |
| Q4 2024 | -$25.20 | +$5.70 |
| Q3 2024 | -$28.50 | +$3.20 |
LONA is still losing money, but less than at its worst: $23.13 per share over the past year, against $31.70 at its worst in late 2023.
LONA Quarterly Revenue
LONA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2024 | -$26M | +$280K |
| Q3 2024 | -$23M | +$991K |
| Q2 2024 | -$22.4M | +$2M |
| Q1 2024 | -$25.8M | +$626K |
| Q4 2023 | -$26.3M | -$10.6M |
| Q3 2023 | -$24M | -$2.1M |
| Q2 2023 | -$24.3M | -$5.6M |
| Q1 2023 | -$26.4M | -$9.1M |
LONA has burned cash in almost every quarter: −$87M over the past year, against −$98M the year before.
LONA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +25% | +4.7M shares |
| 1 year | +508% | +19.8M shares |
| 3 years | +526% | +19.9M shares |
| 5 years | +563% | +20.1M shares |
| Available history | +663% | +20.6M shares |
LONA has 24M diluted shares, up 508% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2020 | — |
| Q1 2020 | — |
| Q4 2019 | — |
| Q3 2019 | — |
LONA Net Leverage
LONA's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
LONA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.9 | Neutral |
| Stochastic | 32.2 | Neutral |
LONA's weekly RSI is 37 (neutral) and its Stochastic is 32 (neutral).
LONA PE vs Healthcare Sector
LONA has no meaningful PE right now: it lost money over the past year.
LONA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.62 | 19% below |
| 20 week MA | $6.48 | 42% below |
| 50 week MA | $7.13 | 48% below |
| 100 week MA | $5.52 | 32% below |
| 200 week MA | $14.6 | 74% below |
LONA is in a downtrend: it's below all five of its weekly moving averages, and 74% below its 200-week average.
LONA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $171.1 | $315.3 | +84% |
| 2021 | $315.3 | $130.1 | -59% |
| 2022 | $130.1 | $30.8 | -76% |
| 2023 | $30.8 | $24.3 | -21% |
| 2024 | $24.3 | $5.50 | -77% |
| 2025 | $5.50 | $7.48 | +36% |
| 2026 YTD | $7.48 | $3.73 | -50% |
LONA has finished lower in four of the last six years. It's down 50% so far in 2026.